EIN 06-1619523

Alliance for Cancer Gene Therapy

IRS 501(c) type
501(c)(3)
Num. employees
2
Year formed
2001
Most recent tax filings
2023-04-01
NTEE code, primary
Description
In fye 04/30/16 acgt funded young investigator grants (awards to newly appointed assistant professors on tenure track and funded clinical investigator grants (awards to investigators conducting clinical translation.) During the year, act also further ...
Total revenues
$3,231,770
2023
Total expenses
$2,498,579
2023
Total assets
$7,929,383
2023
Num. employees
2
2023

Program areas at Alliance for Cancer Gene Therapy

In fiscal 04/30/23, acgt funded clinical investigator grants (awarded to innovative scientists conducting translational research) at premier academic institutions in the u.s,, each focusing on the development of Cancer cell and Gene therapies for different cancers including lung, pancreatic, prostate, ovarian and brain cancers, pediatric sarcomas and Cancer metastasis. In addition, acgt continued multi-year collaborations with other multi-disciplinary 501(c)(3) organizations focused on cell and Gene Therapy research. Acgt further increased public awareness of cell and Gene Therapy research through scientific seminars, acgt's website, social media and available marketing materials.

Grants made by Alliance for Cancer Gene Therapy

GranteeGrant descriptionAmount
Cancer Research Institute (CRI)Cancer Research$750,000
University of California San Francisco / Ucsf Payroll OfficeCancer Research$492,904
University of PittsburghCancer Research$12,057
...and 2 more grants made

Who funds Alliance for Cancer Gene Therapy

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Swim Across America (SAA)Cancer Research$315,000
FJC - A Foundation of Philanthropic FundsGeneral Operating Support$75,000
Fidelity Investments Charitable Gift FundFor Grant Recipient's Exempt Purposes$34,650
...and 13 more grants received

Personnel at Alliance for Cancer Gene Therapy

NameTitleCompensation
Kevin HoneycuttPresident , Chief Executive Officer and Director$0
Barbara LaveryChief Program Officer$235,943
H William SmithVice President , Legal , Secretary$0
Christine HermanVice President , Treasurer$0

Financials for Alliance for Cancer Gene Therapy

RevenuesFYE 04/2023
Total grants, contributions, etc.$2,202,186
Program services$196,753
Investment income and dividends$134,870
Tax-exempt bond proceeds$0
Royalty revenue$395,629
Net rental income$0
Net gain from sale of non-inventory assets$300,263
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$2,069
Total revenues$3,231,770

Form 990s for Alliance for Cancer Gene Therapy

Fiscal year endingDate received by IRSFormPDF link
2023-042024-01-22990View PDF
2022-042023-03-07990View PDF
2021-042022-03-03990View PDF
2020-042021-09-23990View PDF
2019-042019-10-29990View PDF
...and 9 more Form 990s
Data update history
August 10, 2024
Received grants
Identified 5 new grant, including a grant for $75,000 from FJC - A Foundation of Philanthropic Funds
May 27, 2024
Posted financials
Added Form 990 for fiscal year 2023
May 23, 2024
Updated personnel
Identified 2 new personnel
May 18, 2024
Received grants
Identified 2 new grant, including a grant for $7,500 from The Kaufmann Foundation
December 28, 2023
Received grants
Identified 4 new grant, including a grant for $315,000 from Swim Across America (SAA)
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsCharities
Issues
HealthDiseases and disordersCancer
Characteristics
Provides grantsConducts researchNational levelTax deductible donationsAccepts online donations
General information
Address
96 Cummings Point Rd
Stamford, CT 06902
Metro area
Bridgeport-Stamford-Norwalk, CT
County
Western Connecticut Planning Region, CT
Website URL
acgtfoundation.org/ 
Phone
(203) 358-5055
IRS details
EIN
06-1619523
Fiscal year end
April
Taxreturn type
Form 990
Year formed
2001
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H30: Cancer Research
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
California AB-488 details
AB 488 status
May Operate or Solicit for Charitable Purposes
Charity Registration status
Current
FTB status revoked
Not revoked
AG Registration Number
CT0243403
FTB Entity ID
None yet
AB 488 data last updated ("as-of") date
2024-10-16
Free account sign-up

Want updates when Alliance for Cancer Gene Therapy has new information, or want to find more organizations like Alliance for Cancer Gene Therapy?

Create free Cause IQ account